Safety of a New Oral Contraceptive Containing Drospirenone

@article{Heinemann2004SafetyOA,
  title={Safety of a New Oral Contraceptive Containing Drospirenone},
  author={L. Heinemann and J. Dinger},
  journal={Drug Safety},
  year={2004},
  volume={27},
  pages={1001-1018}
}
New chemical entities must undergo rigorous, and preferably independent, safety and efficacy assessments before entry into the market. This is also true for oral contraceptives (OCs) given their extensive usage by healthy women and the safety concerns highlighted by the so-called ‘third generation pill scare’ in Europe a decade ago. This scare heightened patient and physician awareness of the increased risk of thromboembolic complications (mainly venous thromboembolism [VTE]) associated with OC… Expand

Paper Mentions

Observational Clinical Trial
EURAS is a multi-national, controlled, prospective, post-marketing, non-intervention cohort study of new users of drospirenone/ethinylestradiol (DRSP/EE), levonorgestrel… Expand
ConditionsContraception
InterventionDrug
The association between drospirenone and hyperkalemia: a comparative-safety study
Risk of hyperkalemia in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Combined hormonal contraception and venous thromboembolism
  • F. Martínez, À. Avecilla
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2007
Acute Myocardial Infarction Associated With Yasmin Oral Contraceptive
  • G. Ortí, Y. Mira, A. Vayá
  • Medicine
  • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
  • 2007
Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke?
...
1
2
3
4
...

References

SHOWING 1-10 OF 43 REFERENCES
Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing
  • F. Roumen
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 2002
Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
  • A. Rübig
  • Medicine
  • Climacteric : the journal of the International Menopause Society
  • 2003
...
1
2
3
4
5
...